Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NATTOPHARMA AS
AS
Active
Org 987774339
Etasje 05 Mustads Vei 1, 0283
Oslo
Wholesale of other food
·
NACE 4638
Est. 2005 · 21 years old
5 employees
www.nattopharma.com
Monitor
Share
Norway
/
Companies
/
Wholesale of other food
/
NATTOPHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
56M
113M
169M
225M
90M
2020
96M
2021
71M
2022
196M
2023
30M
2024
EBITDA
NOK millions
159M
112M
64M
17M
-30M
1M
2020
-24M
-2500%
2021
-7M
+71%
2022
127M
+1914%
2023
25M
-80%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
89 543
95 925
71 314
196 104
29 582
Staff expenses
−0
−0
−0
−0
−0
EBITDA
897
−24 233
−6 612
127 167
25 251
Depreciation & amort.
−1 369
−4 377
−0
−10 786
−345
EBIT
−472
−28 610
−6 612
116 381
24 906
Net financials
24 435
2 001
108 144
12 978
10 696
Profit before tax
23 963
−26 609
101 532
129 359
35 602
Tax
−28 820
17 820
−8 000
19 000
−0
Net profit
52 783
−44 429
109 532
110 359
35 602
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
233 356
237 389
285 609
234 034
47 555
Equity
201 669
170 151
92 392
67 751
26 292
Long-term debt
0
26 764
2 932
11 858
0
Short-term debt
31 687
40 474
190 285
154 426
21 264
Total debt
31 687
67 238
193 217
166 284
21 264
Financial ratios
5-year trend
EBITDA margin
85.4%
This company
15.8%
Market median
+441% vs market
2020
2024
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
2020
2024
Return on equity
135.4%
This company
18.4%
Market median
+636% vs market
2020
2024
Net profit margin
120.3%
This company
8.1%
Market median
+1385% vs market
2020
2024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
2020
2024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on NATTOPHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
